Weight Loss Drugs May Also Be Longevity Drugs, Researchers Say
Key Points:
- Early research suggests that weight loss drugs like Ozempic and Zepbound, which contain GLP-1 medications, may have potential to slow biological aging, but conclusive evidence is not yet available.
- A study led by Michael Corley found that people with HIV taking semaglutide showed signs of slower biological aging based on blood biomarkers after eight months.
- GLP-1 drugs improve metabolic health, reduce chronic inflammation, and lower risks of heart disease and diabetes, which are linked to aging, leading researchers to hypothesize potential longevity benefits.
- Experts caution that there is currently little evidence these drugs extend lifespan in healthy individuals, and concerns remain about side effects like muscle loss and lower bone density that may impact aging.
- Proven strategies for healthy aging remain exercise, maintaining a healthy weight, managing metabolic health, getting enough sleep, and avoiding smoking, while GLP-1 drugs should only be used under medical guidance for approved conditions.